NN
Novo Nordisk
NVO
OMX NORDIC EXCHANGE COPENHAGEN A/SHealth Care
Income Statement
Total Revenue$41.7B
Gross Profit$35.31B
Operating Income$18.45B
EBITDA$21.02B
EBIT$18.29B
Pre-tax Income$155.68B
Net Income$14.52B
Balance Sheet
Net Cash$211.27B
Cash Equivalent$4.77B
Total Debt$8.71B
Net Debt$-202.56B
Book Value$17.11B
Net Cash Per Share47.60
Book Value Per Share3.79
Key Ratios
Return on Equity (ROE)+70.38%
Return on Assets (ROA)+21.68%
Return on Invested Capital (ROI)+41.01%
Net Profit Margin+34.78%
Current Ratio0.74
Quick Ratio0.55
Long-Term Debt / Equity0.59